• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEDEC-MEIJI FARMA SUPRAHYAL; SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEDEC-MEIJI FARMA SUPRAHYAL; SODIUM HYALURONATE Back to Search Results
Lot Number M-6
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Syncope (1610)
Event Date 05/09/2019
Event Type  Injury  
Event Description
Manufacturer reported that a female of (b)(6) years old with a medical history of arthrosis developed syncope after administration of suprahyal on(b)(6) 2019 with co-administration of platelet growth factors and lidocaine.No problem was evident during the first 30 minutes.After leaving the medical facility the patient developed weakness and syncope.A physician decided she should be observed in the emergency department.The patient was observed at the emergency department and "laboratory studies were normal.After 16 hours approximately the patient is discharged, patient does not refer new symptoms or new episodes.Date of recovery: (b)(6).Medicamenta ecuatoriana pharmacovigilance comment: in the patient it is difficult to determine the etiology of the syncope by the form of administration.The fact of using a combination of products in the same route can cause non-visible effects with each individual product.Relatedness of drug to reaction(s): medicinal product: suprahyal 25 mg x 1 iny x 1 jer solucion inyectable - drug reaction assess: syncope - source of assessment: tmf - method of assessment: karl-lasagna algorithm (amended) - causality assessment: possible.Manufacturer's comment: the causal role of sodium hyaluronate in the event developed cannot be ruled out as well as the other drugs administered in the same injection.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPRAHYAL
Type of Device
SODIUM HYALURONATE
Manufacturer (Section D)
TEDEC-MEIJI FARMA
s.a. ctra. m-300,
km. 30,500-28802
alcalá de henares, madrid,
SP 
Manufacturer Contact
dolores benedicto
ctra. m-300,
km. 30,500-28802
alcala de henares madrid, 
SP  
MDR Report Key8755609
MDR Text Key149925955
Report Number3003184440-2019-00002
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial
Report Date 06/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date09/01/2021
Device Lot NumberM-6
Initial Date Manufacturer Received 06/04/2019
Initial Date FDA Received07/02/2019
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age73 YR
-
-